Overview
Simon Skalicky practices in Melbourne, Australia. Mr. Skalicky is highly rated in 5 conditions, according to our data. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.
His clinical research consists of co-authoring 54 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GlaucomaMr. Skalicky isDistinguished. Learn about Glaucoma.
- Ocular Hypertension (OHT)Mr. Skalicky isDistinguished. Learn about Ocular Hypertension (OHT).
- Pigment-Dispersion SyndromeMr. Skalicky isDistinguished. Learn about Pigment-Dispersion Syndrome.
- TrabeculectomyMr. Skalicky isDistinguished. Learn about Trabeculectomy.
- Advanced
- CataractMr. Skalicky isAdvanced. Learn about Cataract.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Skalicky isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Cataract RemovalMr. Skalicky isExperienced. Learn about Cataract Removal.
- Ganglion CystMr. Skalicky isExperienced. Learn about Ganglion Cyst.
- Geographic AtrophyMr. Skalicky isExperienced. Learn about Geographic Atrophy.
- Hereditary SpherocytosisMr. Skalicky isExperienced. Learn about Hereditary Spherocytosis.
- IridectomyMr. Skalicky isExperienced. Learn about Iridectomy.